Search Results - "Stuetz, Anton"

Refine Results
  1. 1

    NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo by Jalili, Ahmad, Mertz, Kirsten D, Romanov, Julia, Wagner, Christine, Kalthoff, Frank, Stuetz, Anton, Pathria, Gaurav, Gschaider, Melanie, Stingl, Georg, Wagner, Stephan N

    Published in PloS one (30-07-2013)
    “…Melanoma is one of the most aggressive cancers and its incidence is increasing worldwide. So far there are no curable therapies especially after metastasis…”
    Get full text
    Journal Article
  2. 2

    Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application by WEISS, H. Markus, FRESNEAU, Marcel, MOENIUS, Thomas, STUETZ, Anton, BILLICH, Andreas

    Published in Drug metabolism and disposition (01-09-2008)
    “…Pimecrolimus and tacrolimus are calcineurin inhibitors used for the topical treatment of atopic dermatitis. Although structurally similar, they display…”
    Get full text
    Journal Article
  3. 3

    Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin by Meingassner, Josef G., Aschauer, Heinrich, Stuetz, Anton, Billich, Andreas

    Published in Experimental dermatology (01-10-2005)
    “…:  The permeabilities of normal human and normal, inflamed, or corticosteroid (CS) pretreated skin of young domestic pigs for pimecrolimus and tacrolimus were…”
    Get full text
    Journal Article
  4. 4

    Synthesis and Structure-Activity Relationships of Side-Chain-Substituted Analogs of the Allylamine Antimycotic Terbinafine Lacking the Central Amino Function by Nussbaumer, Peter, Leitner, Ingrid, Mraz, Karin, Stuetz, Anton

    Published in Journal of medicinal chemistry (01-05-1995)
    “…Terbinafine is a therapeutically used inhibitor of fungal squalene epoxidase that has prompted extensive derivatization programs for structure-activity…”
    Get full text
    Journal Article
  5. 5
  6. 6

    SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7 by Wang, Shirley, Olt, Sabine, Schoefmann, Nicole, Stuetz, Anton, Winiski, Anthony, Wolff-Winiski, Barbara

    Published in Experimental dermatology (01-07-2014)
    “…Netherton syndrome (NS; OMIM 256500) is a genetic skin disease resulting from defects in the serine protease inhibitor Kazal‐type 5 (SPINK5) gene, which…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor by Halin, Cornelia, Fahrngruber, Hermann, Meingassner, Josef G, Bold, Guido, Littlewood-Evans, Amanda, Stuetz, Anton, Detmar, Michael

    Published in The American journal of pathology (01-07-2008)
    “…Although vascular remodeling is a hallmark of many chronic inflammatory disorders, antivascular strategies to treat these conditions have received little…”
    Get full text
    Journal Article
  9. 9

    Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus by Billich, Andreas, Aschauer, Heinrich, Aszódi, András, Stuetz, Anton

    Published in International journal of pharmaceutics (09-01-2004)
    “…For treatment of skin diseases with topical drugs, penetration of the agents into the relevant layers of the skin is required. Permeation through the skin…”
    Get full text
    Journal Article
  10. 10

    Mechanical and Metabolic Injury to the Skin Barrier Leads to Increased Expression of Murine β-Defensin-1, -3, and -14 by Ahrens, Kerstin, Schunck, Michael, Podda, Graziella-Francesca, Meingassner, Josef, Stuetz, Anton, Schröder, Jens-Michael, Harder, Jürgen, Proksch, Ehrhardt

    Published in Journal of investigative dermatology (01-02-2011)
    “…Protection of the skin against microbiological infection is provided by the permeability barrier and by antimicrobial proteins. We asked whether the expression…”
    Get full text
    Journal Article
  11. 11

    Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes by Büchau, Amanda S., Schauber, Jürgen, Hultsch, Thomas, Stuetz, Anton, Gallo, Richard L.

    Published in Journal of investigative dermatology (01-11-2008)
    “…Calcineurin inhibitors are potent inhibitors of T-cell-receptor mediated activation of the adaptive immune system. The effects of this class of drug on the…”
    Get full text
    Journal Article
  12. 12

    Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics by Stuetz, Anton, Georgopoulos, Apostolos, Granitzer, Waltraud, Petranyi, Gabor, Berney, Daniel

    Published in Journal of medicinal chemistry (01-01-1986)
    “…Naftifine (1) is the first representative of the new antifungal allylamine derivatives. Its biological activity is strictly bound to specific structural…”
    Get full text
    Journal Article
  13. 13
  14. 14

    SPINK 5 knockdown in organotypic human skin culture as a model system for N etherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7 by Wang, Shirley, Olt, Sabine, Schoefmann, Nicole, Stuetz, Anton, Winiski, Anthony, Wolff‐Winiski, Barbara

    Published in Experimental dermatology (01-07-2014)
    “…Abstract Netherton syndrome ( NS ; OMIM 256500) is a genetic skin disease resulting from defects in the serine protease inhibitor K azal‐type 5 ( SPINK 5)…”
    Get full text
    Journal Article
  15. 15

    Corticosteroids But Not Pimecrolimus Affect Viability, Maturation and Immune Function of Murine Epidermal Langerhans Cells by Hoetzenecker, Wolfram, Meingassner, Josef G., Ecker, Rupert, Stingl, Georg, Stuetz, Anton, Elbe-Bürger, Adelheid

    Published in Journal of investigative dermatology (01-03-2004)
    “…Given the importance of dendritic cells in the immune response, we investigated the effect of corticosteroids (CS) on the integrity, survival, and function of…”
    Get full text
    Journal Article
  16. 16

    Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis by Hoetzenecker, Wolfram, Ecker, Rupert, Kopp, Tamara, Stuetz, Anton, Stingl, Georg, Elbe-Bürger, Adelheid

    Published in Journal of Allergy and Clinical Immunology (01-06-2005)
    “…Apart from the long-used corticosteroids, topical calcineurin inhibitors (tacrolimus, pimecrolimus) represent novel therapeutic options for the treatment of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Pimecrolimus for the treatment of inflammatory skin disease by Wolff, Klaus, Stuetz, Anton

    Published in Expert opinion on pharmacotherapy (01-03-2004)
    “…Pimecrolimus (SDZ ASM 981, Elidel ) is an ascomycin macrolactam derivative and a cell-selective inhibitor of inflammatory cytokines specifically developed to…”
    Get more information
    Journal Article
  20. 20

    Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus by Stuetz, Anton, Baumann, Karl, Grassberger, Maximilian, Wolff, Klaus, Meingassner, Josef G

    “…Using a newly developed model of allergic contact dermatitis in pigs, calcineurin inhibitors of the tacrolimus and ascomycin type were shown to have a highly…”
    Get full text
    Journal Article